(Q48840116)

English

Effects of 100 mg of controlled-release metoprolol and 100 mg of atenolol on blood pressure, central nervous system-related symptoms, and general well being.

scientific article published in July 1994

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/7929868

Effects of 100 mg of controlled-release metoprolol and 100 mg of atenolol on blood pressure, central nervous system-related symptoms, and general well being. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/7929868

author name string

Walle PO

1

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/7929868

Westergren G

2

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/7929868

Dimenäs E

3

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/7929868

Olofsson B

4

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/7929868

Albrektsen T

5

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/7929868

publication date

1 July 1994

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/7929868

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/7929868

34

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/7929868

7

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/7929868

742-747

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/7929868

Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB02034.X

21 January 2018

Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB02034.X

21 January 2018

Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB02034.X

21 January 2018

Lipophilicity, hydrophilicity, and the central nervous system side effects of beta blockers

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB02034.X

21 January 2018

Pharmacologic and physiologic considerations of adrenoceptor blockade.

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB02034.X

21 January 2018

Central nervous system effects of beta-adrenergic-blocking drugs: the role of ancillary properties

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB02034.X

21 January 2018

Central effects of beta-adrenoceptor antagonists

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB02034.X

21 January 2018

Can the biochemical responses to a beta 2-adrenoceptor stimulant be used to assess the selectivity of beta-adrenoceptor blockers?

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB02034.X

21 January 2018

Beta-adrenoceptor blockers and the blood-brian barrier

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB02034.X

21 January 2018

Pharmacokinetic and biopharmaceutic aspects of once daily treatment with metoprolol CR/ZOK: a review article

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB02034.X

21 January 2018

Controlled release metoprolol. Clinical pharmacokinetic and therapeutic implications

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB02034.X

21 January 2018

Documentation of an instrument for assessment of subjective CNS-related symptoms during cardiovascular pharmacotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB02034.X

21 January 2018

Comparison of CNS-related subjective symptoms in hypertensive patients treated with either a new controlled release (CR/ZOK) formulation of metoprolol or atenolol

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB02034.X

21 January 2018

Identifiers

10.1002/J.1552-4604.1994.TB02034.X

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/7929868

release_4rhcxlwkpzhcna5pjsk2pb7x4e

1 reference

https://api.fatcat.wiki/v0/release/4rhcxlwkpzhcna5pjsk2pb7x4e

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/7929868

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48840116&oldid=1843312467"